Latest filing published 03 Jun 2026 for CVRx, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kevin J. Ballinger discloses dealings in 4 companies, chiefly Silk Road Medical Inc, Boston Scientific Corp and Shockwave Medical, Inc. In total, 14 filings cover trades dated from 1 January 2016 to 1 June 2026.
Both buying and selling appear: 1 purchase worth €183k, against 2 sales. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 8 share grants and 1 option exercise.
The latest filing, published on 3 June 2026, reports a share grant in CVRx, Inc. The last purchase on record was published on 7 March 2024, which is 955 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations